메뉴 건너뛰기




Volumn 158, Issue 5, 2011, Pages

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PLACEBO;

EID: 79954418109     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.10.031     Document Type: Article
Times cited : (292)

References (12)
  • 1
    • 33745170709 scopus 로고    scopus 로고
    • Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease
    • DOI 10.1161/CIRCULATIONAHA.105.592865, PII 0000301720060606000009
    • T. Kobayashi, Y. Inoue, K. Takeuchi, Y. Okada, K. Tamura, and T. Tomomasa Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease Circulation 113 2006 2606 2612 (Pubitemid 43948009)
    • (2006) Circulation , vol.113 , Issue.22 , pp. 2606-2612
    • Kobayashi, T.1    Inoue, Y.2    Takeuchi, K.3    Okada, Y.4    Tamura, K.5    Tomomasa, T.6    Kobayashi, T.7    Morikawa, A.8
  • 2
    • 33845905197 scopus 로고    scopus 로고
    • Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
    • DOI 10.1007/s00431-006-0223-z
    • T. Sano, S. Kurotobi, K. Matsuzaki, T. Yamamoto, I. Maki, and K. Miki Predition of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment Eur J Pediatr 166 2007 131 137 (Pubitemid 46025504)
    • (2007) European Journal of Pediatrics , vol.166 , Issue.2 , pp. 131-137
    • Sano, T.1    Kurotobi, S.2    Matsuzaki, K.3    Yamamoto, T.4    Maki, I.5    Miki, K.6    Kogaki, S.7    Hara, J.8
  • 3
    • 33746385382 scopus 로고    scopus 로고
    • Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
    • DOI 10.1016/j.jpeds.2006.03.050, PII S0022347606002721
    • K. Egami, H. Muta, M. Ishii, K. Suda, Y. Sugahara, and M. Iemura Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease J Pediatr 149 2006 237 240 (Pubitemid 44128552)
    • (2006) Journal of Pediatrics , vol.149 , Issue.2 , pp. 237-240
    • Egami, K.1    Muta, H.2    Ishii, M.3    Suda, K.4    Sugahara, Y.5    Iemura, M.6    Matsuishi, T.7
  • 4
    • 67649623214 scopus 로고    scopus 로고
    • Diagnosis and treatment of Kawasaki Disease: Analysis of 27 US pediatric hospitals from 2001-2006
    • M.F. Son, K. Gauvreau, L. Ma, A.L. Baker, R.P. Sundel, and D.R. Fulton Diagnosis and treatment of Kawasaki Disease: analysis of 27 US pediatric hospitals from 2001-2006 Pediatrics 124 2009 1 8
    • (2009) Pediatrics , vol.124 , pp. 1-8
    • Son, M.F.1    Gauvreau, K.2    Ma, L.3    Baker, A.L.4    Sundel, R.P.5    Fulton, D.R.6
  • 5
    • 0032411505 scopus 로고    scopus 로고
    • Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
    • DOI 10.1097/00006454-199812000-00009
    • J.C. Burns, E.V. Capparelli, J.A. Brown, J.W. Newburger, and M.P. Glode Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group Pediatr Infect Dis J 17 1998 1144 1148 (Pubitemid 29023891)
    • (1998) Pediatric Infectious Disease Journal , vol.17 , Issue.12 , pp. 1144-1148
    • Burns, J.C.1    Capparelli, E.V.2    Brown, J.A.3    Newburger, J.W.4    Glode, M.P.5
  • 7
    • 31944441023 scopus 로고    scopus 로고
    • Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease
    • DOI 10.1080/08035250500327328, PII G7RM73504431J1RR
    • H. Muta, M. Ishii, J. Furui, Y. Nakamura, and T. Matsuishi Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease Acta Paediatrica 95 2006 189 193 (Pubitemid 43189012)
    • (2006) Acta Paediatrica, International Journal of Paediatrics , vol.95 , Issue.2 , pp. 189-193
    • Muta, H.1    Ishii, M.2    Furui, J.3    Nakamura, Y.4    Matsuishi, T.5
  • 11
    • 49349093008 scopus 로고    scopus 로고
    • Risk factors for nonresponse to therapy in Kawasaki Disease
    • N. Ashouri, M. Takahashi, F. Dorey, and W. Mason Risk factors for nonresponse to therapy in Kawasaki Disease J Pediatr 153 2008 365 368
    • (2008) J Pediatr , vol.153 , pp. 365-368
    • Ashouri, N.1    Takahashi, M.2    Dorey, F.3    Mason, W.4
  • 12
    • 69949105260 scopus 로고    scopus 로고
    • Corticosteroid therapy for primary treatment of Kawasaki disease - Weight of evidence: A meta-analysis and systematic review of the literature
    • G. Athappan, S. Gale, and T. Ponniah Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature Cardiovasc J Afr 20 2009 233 236
    • (2009) Cardiovasc J Afr , vol.20 , pp. 233-236
    • Athappan, G.1    Gale, S.2    Ponniah, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.